Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis L Pisters

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
BJU International|October 19, 2016
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancerMario I Fernández, Stephen B Williams, Daniel L Willis, et al.
Science Translational Medicine|April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancerSumit K Subudhi, Luis Vence, Hao Zhao, et al.
BJU International|June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillanceJohn W Davis, John F Ward, Curtis A Pettaway, et al.
BJU International|June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlatesAndrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
Cancer|March 29, 2016
Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancerShi-Ming Tu, Mehmet Asim Bilen, Kenneth R Hess, et al.
BJU International|September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohortPierre Blanchard, John W Davis, Steven J Frank, et al.
Cancer Research|January 30, 2014
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancerJohn R Prensner, Wei Chen, Matthew K Iyer, et al.
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolas Anselmino, Estefania Labanca, Peter D A Shepherd, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
BJU International|October 19, 2016
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancerMario I Fernández, Stephen B Williams, Daniel L Willis, et al.
Science Translational Medicine|April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancerSumit K Subudhi, Luis Vence, Hao Zhao, et al.
BJU International|June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillanceJohn W Davis, John F Ward, Curtis A Pettaway, et al.
BJU International|June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlatesAndrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
Cancer|March 29, 2016
Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancerShi-Ming Tu, Mehmet Asim Bilen, Kenneth R Hess, et al.
BJU International|September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohortPierre Blanchard, John W Davis, Steven J Frank, et al.
Cancer Research|January 30, 2014
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancerJohn R Prensner, Wei Chen, Matthew K Iyer, et al.
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolas Anselmino, Estefania Labanca, Peter D A Shepherd, et al.
Pageof 17